Trial Profile

Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III - Geriatric Assessment and Prognostic Gene Signatures

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Capecitabine (Primary)
Indications Adenocarcinoma; Colon cancer
Focus Therapeutic Use
Acronyms ACE

Most Recent Events

05 Sep 2025 Status changed from active, no longer recruiting to completed.
19 Apr 2022 Planned primary completion date changed from 1 Nov 2021 to 1 Nov 2022.
08 Sep 2021 Planned primary completion date changed from 1 Apr 2021 to 1 Nov 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com